| FWMMX | IRLCX | FWMMX / IRLCX | |
| Total Expense Ratio | 0.35 | 0.61 | 57% |
| Annual Report Gross Expense Ratio | 0.35 | 0.87 | 40% |
| Fund Existence | 6 years | 18 years | - |
| Gain YTD | 4.996 | 3.948 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 219B | 1.07B | 20,563% |
| Annual Yield % from dividends | 1.39 | 1.29 | 108% |
| Returns for 1 year | 6.98 | 13.45 | 52% |
| Returns for 3 years | 27.89 | 59.80 | 47% |
| Returns for 5 years | 31.36 | 62.76 | 50% |
| Returns for 10 years | N/A | 231.42 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BQLCX | 23.42 | 0.17 | +0.73% |
| Bright Rock Quality Large Cap Instl | |||
| GSPKX | 20.05 | 0.12 | +0.60% |
| Goldman Sachs US Eq Div and Prem Instl | |||
| BIAUX | 32.33 | 0.06 | +0.19% |
| Brown Advisory Small-Cap Fdmtl Val Inv | |||
| GSIQX | 23.62 | N/A | N/A |
| Goldman Sachs GQG Ptnrs Intl Opps R | |||
| RYOAX | 66.89 | -1.55 | -2.26% |
| Rydex Biotechnology H | |||